These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 33377904)
1. Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019. Tarras ES; Marshall DC; Rosenzweig K; Korenstein D; Chimonas S JAMA Oncol; 2021 Mar; 7(3):440-444. PubMed ID: 33377904 [TBL] [Abstract][Full Text] [Related]
2. Trends in Financial Relationships Between Industry and Radiation Oncologists Versus Other Physicians in the United States from 2014 to 2018. Marshall DC; Tarras ES; Rosenzweig K; Yom SS; Hattangadi-Gluth J; Murphy J; Korenstein D; Chimonas S Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):15-25. PubMed ID: 32858112 [TBL] [Abstract][Full Text] [Related]
3. Types and Distribution of Payments From Industry to Physicians in 2015. Tringale KR; Marshall D; Mackey TK; Connor M; Murphy JD; Hattangadi-Gluth JA JAMA; 2017 May; 317(17):1774-1784. PubMed ID: 28464140 [TBL] [Abstract][Full Text] [Related]
4. Distribution and Patterns of Industry-Related Payments to Oncologists in 2014. Marshall DC; Moy B; Jackson ME; Mackey TK; Hattangadi-Gluth JA J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27389914 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology. Mitchell AP; Winn AN; Lund JL; Dusetzina SB Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276 [TBL] [Abstract][Full Text] [Related]
6. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017. Rahman MW; Trivedi NU; Bach PB; Mitchell AP J Natl Compr Canc Netw; 2021 Dec; 20(13):1-9. PubMed ID: 34965511 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists. Weng JK; Valle LF; Nam GE; Chu FI; Steinberg ML; Raldow AC JAMA Netw Open; 2019 Jan; 2(1):e187377. PubMed ID: 30681710 [TBL] [Abstract][Full Text] [Related]
8. Industry payments to US physicians for cancer therapeutics: An analysis of the 2016-2018 open payments datasets. Meyers DE; Chisamore TM; McInnes MDF; Gyawali B; Prasad V; Booth CM J Cancer Policy; 2021 Jun; 28():100283. PubMed ID: 35559912 [TBL] [Abstract][Full Text] [Related]
9. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database. Jairam V; Yu JB Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386 [TBL] [Abstract][Full Text] [Related]
10. Nine-Year Analysis of Industry Payments to Geriatricians in the United States Between 2014 and 2022. Murayama A J Am Med Dir Assoc; 2024 Jun; 25(6):104840. PubMed ID: 37918817 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis. Ozaki A; Saito H; Onoue Y; Sawano T; Shimada Y; Somekawa Y; Tsuji A; Tanimoto T BMJ Open; 2019 Sep; 9(9):e028805. PubMed ID: 31494604 [TBL] [Abstract][Full Text] [Related]
12. A 9-Year Investigation of Healthcare Industry Payments to Pulmonologists in the United States. Murayama A; Kugo H; Saito Y; Saito H; Tanimoto T; Ozaki A Ann Am Thorac Soc; 2023 Sep; 20(9):1283-1292. PubMed ID: 36961514 [No Abstract] [Full Text] [Related]
13. Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians? Wright K; Meyers DE; Chisamore TM; McInnes MDF; Sismondo S; Gyawali B; Prasad V; Booth CM JCO Oncol Pract; 2022 Jul; 18(7):e1164-e1169. PubMed ID: 35696634 [TBL] [Abstract][Full Text] [Related]
14. Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021. Murayama A; Kamamoto S; Kugo H; Saito H; Ozaki A J Am Soc Nephrol; 2023 Oct; 34(10):1709-1720. PubMed ID: 37488676 [TBL] [Abstract][Full Text] [Related]
15. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines. Mitchell AP; Mishra A; Dey P; Curry MA; Trivedi NU; Haddadin M; Rahman MW; Winn AN; Dusetzina SB; Bach PB Oncologist; 2021 Sep; 26(9):771-778. PubMed ID: 33982829 [TBL] [Abstract][Full Text] [Related]
16. Industry Payments to Practicing US Rheumatologists, 2014-2019. Putman MS; Goldsher JE; Crowson CS; Duarte-García A Arthritis Rheumatol; 2021 Nov; 73(11):2138-2144. PubMed ID: 34164951 [TBL] [Abstract][Full Text] [Related]
17. Trends in Industry Payments to Physicians in the First 6 Years After Graduate Medical Training. Han M; Hogan SO; Holmboe E; Jing Y; Yamazaki K; Trock BJ JAMA Netw Open; 2022 Oct; 5(10):e2237574. PubMed ID: 36260332 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021. Singh A; Hyman MJ; Modi PK JAMA Netw Open; 2022 Nov; 5(11):e2242869. PubMed ID: 36399340 [TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set. Schnog JB; Samson MJ; Gersenbluth I; Duits AJ JCO Oncol Pract; 2024 Jun; 20(6):843-851. PubMed ID: 38354335 [TBL] [Abstract][Full Text] [Related]
20. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018. Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]